Clear Harbor Asset Management, LLC
Position in ALLO — Allogene Therapeutics, Inc.
CIK 1511857
Stamford, CT
Position in ALLO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$20,800
-$3,600 QoQ
Shares Held
10,000
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#172
of 207 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALLO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Clear Harbor Asset Management, LLC holds $6,083,006 across 9 Biotechnology names. ALLO ranks #8 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
7,610 | $4,745,139 | |
| 2 | ANAB |
Anaptysbio, Inc
|
11,550 | $779,625 | |
| 3 | QURE |
uniQure N.V.
|
4,300 | $198,058 | |
| 4 | ABUS |
Arbutus Biopharma Corp
|
27,000 | $129,600 | |
| 5 | IBRX |
ImmunityBio, Inc.
|
10,000 | $87,550 | |
| 6 | CABA |
Cabaletta Bio, Inc.
|
19,500 | $60,645 | |
| 7 | CNTX |
Context Therapeutics Inc.
|
92,804 | $51,413 | |
| 8 | ALLO |
Allogene Therapeutics, Inc.
This page
|
10,000 | $20,800 |
All Filings in ALLO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,800 | 10,000 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $24,400 | 10,000 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $13,700 | 10,000 | Shares | Sole | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||